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4 Abstract Asthma is an inflammatory chronic disease characterized by airway
5 obstructions disorders. The treatment is usually done by inhalation therapy, in
6 which pressurized metered-dose inhalers (pMDIs) are a preferred device. The
7 objective of this paper is to characterize and simulate a pMDI spray plume by
8 introducing realistic factors through a computational fluid dynamics (CFD) study.
9 Numerical simulations were performed with Fluent software, by using a three-
10 dimensional ‘‘testbox’’ for room environment representation. An HFA-134a with
11 salbutamol formulation was used for characterization, whose were taken as input
12 for the CFD simulations. Spray droplets were considered to be composed by
13 ethanol, salbutamol and HFA-134a. Propellant evaporation was taken into
14 consideration, as well as, drag coefficient correction. Results showed an air tem-
15 perature drop of 3.3 C near the nozzle. Also, an increase in air velocity of 3.27 m/s
16 was noticed. The CFD results seem to be in good agreement with Dunbar (1997)
17 data on particle average velocity along the axial distance from the nozzle.
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20
21 1 Introduction
22 The inhalation therapy is a cornerstone in treatment of airway diseases. Asthma is
23 a chronic inflammatory disorder associated with airway hyper responsiveness,
24 which can be characterized by episodes of wheezing, breathing difficulties, chest
25 tightness and coughing [1]. More than 300 million worldwide are affected by this
26 disease which is responsible for the death of 220 thousand per year, growing at a
27 rate of 50 % per decade [2]. Anti-inflammatory and bronchodilator drugs are used
28 with the objective of reducing the inflammation of the pulmonary tissue, which
29 causes the diameter reduction of the bronchus [3].
30 Pressurized metered-dose inhalers (pMDIs) are one of the major aerosol-
31 generating devices used for aerosol delivery of bronchodilators in ambulatory
32 patients [4]. Drug dose effectiveness in inhaled delivery is difficult to measure due to
33 the fact that only a small fraction of the pMDI nominal dose reaches the lower
34 respiratory tract. The pMDI is a small, cost-effective and very portable device
35 containing between 100 and 400 doses. This device comprises a disposable canister
36 with a pressurized mixture of propellants, surfactants, preservatives, flavoring
37 agents and active drugs. This mixture is released from the canister through a
38 metering valve [4].
39 The particle size of the aerosol produced by a pMDI depends on the pressure of
40 the propellant mixture, ambient temperature, valve design, drug concentration and
41 actuator orifices. In fact, there is a relationship between the actuator nozzle
42 diameter and the particle size distribution, as well as, the ethanol concentration [5].
43 Moreover, the effectiveness of pMDIs is deeply associated with how the metering
44 valve delivers, in an accurately and reproducibly manner, a measured volume and
45 how it forms a propellant-tight seal for high pressure. According to Dhand [4], high-
46 vapor-pressure propellants produce finer aerosol sprays, whereas increasing the drug
47 concentration increases aerosol particle size. The actuator nozzle controls the
48 atomization process in order to guarantee the formation of a spray plume. The can-
49 ister, typically made of aluminum, holds a high internal pressure of 3–5 atm [6–8].
50 The application of computational fluid dynamics (CFD) in the design of aerosol
51 drug delivery technologies has been proved to be a valuable tool when inhaler
52 performance is investigated. The pMDI actuation is a complex phenomenon which
53 involves turbulent flow, multiple phases, heat and mass transfer between the
54 droplets and the environment. Several studies have been developed in order to
55 model, numerically, pharmaceutical aerosols as a multi-phase flow, in which
56 inhaled air is the continuous phase and the particles or droplets the discrete phase.
57 Dunbar et al. [9], performed a theoretical investigation of a pMDI spray by a
58 CFD study consisting on the construction of actuator flow from the metered
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59 chamber to the nozzle, which was based on a quasi-steady-state for flow analysis
60 during a single actuation. The objective was to examine droplet formation and its
61 trajectory during the inhaler actuation. The predicted results were validated against
62 experimental data obtained using phase Doppler particle analysis (PDPA). Com-
63 paring the numerical results with the experimental data, it was observed that for a
64 distance of 25 mm from the spray orifice, the droplet velocity and size distributions
65 are in agreement, although such correlation does not hold further downstream [9].
66 Kleinstreuer et al. [10], experimentally validated a computational fluid-particle
67 dynamics model developed to simulate the airflow, droplet spray transport and
68 aerosol deposition in a pMDI considering several conditions, including different
69 nozzle diameters and the use of a spacer. Also, the properties of both chloro-
70 fluorocarbon (CFC) and hydrofluoroalkane-134a (HFA) were investigated. The
71 results indicated that the use of HFA, smaller valve orifices and the inclusion of
72 spacers yields the best performance in terms of droplets deposition. Smyth et al.
73 [11] also performed a spray pattern analysis for pMDIs, studying the influence of
74 orifice size, particle size, and droplet motion correlations.
75 Recently, Ruzycki et al. [12] presented a comprehensive review in the use of
76 CFD in inhaler design. The authors enlightened that the application of CFD
77 modeling techniques for pMDIs, nebulizers and DPIs improves the aerosol
78 transport and deposition understanding and, therefore, allows for an intuitive
79 optimization of inhaler technologies whereas saving time and resources.
80 Previous studies in the simulation of the pMDI spray plume were made by the
81 authors [13–16]. After an extensive review of the pMDI properties and charac-
82 teristics, a CFD simulation was made but considering the particles to be solid (i.e.
83 made of active pharmaceutical ingredient) [15].
84 This work aims to characterize and simulate a pMDI spray by means of a
85 commercial CFD software (i.e. Fluent v14.0 from ANSYS). A pMDI salbuta-
86 mol formulation was used for characterization. CFD simulations were performed
87 in a three-dimensional ‘‘testbox’’. Spray droplets were injected and tracked
88 accounting for propellant evaporation, aerodynamic size distribution, gravity,
89 Brownian motion, drag coefficient corrections, turbulence and energy exchange.
90 The input injection file was created using a Python language script.
91 2 Spray Characterization
92 2.1 Spray Dynamics
93 The spray dynamics can be effectively evaluated through images obtained by using
94 a high speed digital video camera. This technique is able to record up to 10,000
95 frames per second, which is very suitable for understanding and capturing details of
96 transient phenomena despite the difficulties related with the illumination required.
97 Specifically for the delivery of aerosol drugs, the potential of such technique is
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98 suitable due to the very nature of the spray exiting from a high pressure canister.
99 Nevertheless, the greatest advantage of this technique is its ability to capture the
100 transient nature of the aerosol formation over the delivery time.
101 Using a high-speed camera (FASTCAM-APX RS 250KC), a puff event from
102 the pMDI HFA-134a spray was recorded. Images were captured with an interval of
103 0.02 s (see Fig. 1). Those were taken at a rate of 6,000 frames per second,
104 allowing to confirm the duration of the spray (0.1 s) and to calculate the spray
105 angle (approximately 17) by visual analysis.
106 2.2 Aerodynamic Size Distribution
107 Particle size distribution can be characterized either as Probability Density
108 Function (PDF) or as a Cumulative Distribution Function (CDF). A particle size
109 distribution is usually denoted by an independent variable, x, and two additional
110 adaptable parameters [17].
111 The spray particle/droplets can be described through different mathematical
112 distributions, being the Log-Normal, Rosin-Rammler and Nukiyama-Tanasawa the
113 most cited. Amongst these distributions, it is well accepted that the pharmaceutical
Fig. 1 High speed images of a puff taken from a salbutamol HFA-134a pMDI. These images
were treated with greyscale and inverted colors after application of a threshold filter for easier
visualization of the plume
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114 aerosols can be reasonable represented by the Log-Normal distribution fitting the
115 measured data to the CDF as shown by Eq. (1). The Log-Normal PDF (Eq. 2) was
116 derived from the normal distribution [17].
117
F x; l; rð Þ ¼ 1
2
erfc  ln x  l
r
ﬃﬃﬃ
2
p
 
ð1Þ
119
120
121
f x; l; rð Þ ¼ 1
xr
ﬃﬃﬃﬃﬃ
2p
p e ln xlð Þ2=2r2 ð2Þ
123 where r is the geometric standard deviation (which shall be= 0), l represents the
124 mean diameter and erfc is the complementary error function. Using the laser
125 diffraction analysis technique (Malvern 2,600 particle sizer), a pMDI spray plume
126 of HFA-134a formulation of salbutamol was measured. Data were fitted to the
127 Log-Nornal CDF distribution model (1) using the least-squares method. Through
128 the calculation of the Pearson coefficient of determination (i.e. R2-squared value)
129 and its maximization (R2 = 0.993), the distribution parameters were obtained:
130 l = 2.55 and r = 0.634. Such values are in agreement with those usually reported
131 in the literature. The experimental results and its Log-Normal CDF curve are
132 shown in Fig. 2.
133 2.3 Axial Velocity
134 The velocity of the droplets decreases along the axial distance from the nozzle, due
135 the momentum exchange with the air. As reported by Dunbar [18], using PDPA
136 measurements of a HFA-134a spray plume during an actuation, values were taken
Fig. 2 Graphical representation of the pMDI HFA-134a salbutamol experimental data and its
fitting for the log-normal CDF distribution. Measurements obtained at 100 mm from the laser
beam
AQ1
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137 at different distances from the nozzle of the actuator. Consistent with their mea-
138 surements, Dunbar concluded that a HFA propellant formulation produces a spray
139 with higher velocities than a CFC formulation. This feature is due to the higher
140 vapor pressure used in the HFA formulation. The plume behaves like a spray up to
141 a distance of 75 mm from the nozzle and as an aerosol downstream that distance,
142 where the droplet motion is being influenced by the gas [18].
143 2.4 Particle Shape and Size
144 Using an optical microscope (Leica DM 2,500 M) for the visual analysis of the
145 particle shape and size, a set of images were taken. After a single puff being
146 discharged against a glass plate, it was observed under the microscope at two
147 different magnifications (see Fig. 3). It is possible to observe that the particles
148 present a very irregular shape, although a limitation of the technique is the reduced
149 depth of field. Also, it can be noticed that some particles present a solid craggy
150 surface (i.e. salbutamol sulfate crystals) and others are encapsulated within a
151 smooth spherical droplet of propellant that did not evaporate.
152 3 Spray Simulation
153 The pMDI is one of the most common drug delivery devices used in developed
154 countries to treat asthma in children and adults. It mainly consists of salbutamol,
155 which is the most frequently prescribed short-acting b-agonist (SABA) [7, 19, 20].
156 This CFD study accounts for the temperature, velocity, turbulence, droplet
157 tracking and evaporation of its propellant, as well as, its concentration in the air.
Fig. 3 Graphical representation of the pMDI HFA-134a salbutamol experimental data and its
fitting for the log-normal CDF distribution. Measurements obtained at 100 mm from the laser
beam
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158 3.1 Spray Injection Properties
159 The most important characteristics of the pMDI spray for the simulation are: spray
160 cone angle (see Sect. 2.1); initial velocity (considered 100 m/s [8, 21]); aerody-
161 namic size distribution; components present in the formulation; nozzle diameter
162 (i.e. 0.25 mm [8, 10, 11, 21]); temperature (i.e. 215 K [22]); and mass flow rate.
163 The aerodynamic size distribution parameters, discussed above in Sect. 2.2, used
164 to configure the injection input file ranged from 1.22 to 49.5 lm, distributed along
165 80 intervals. From the knowledge of the drug dose delivered per puff labeled by
166 the manufacturer (i.e. 100 lg) and the puff duration discussed in Sect. 2.1 (i.e.
167 0.1 s), a spray mass flow rate of 1.0E-6 kg/s was estimated.
168 For the creation of the input injection file, a Python language script was pro-
169 grammed. Into this file, the injections are placed, by a uniform random distribu-
170 tion, within the nozzle area. Properties such as diameter, temperature, and mass
171 flow rate are attributed to each injection. After that assignment, the corresponding
172 velocity components for each injection are calculated. They are calculated
173 according to their distance to the center of the nozzle, so that their initial velocity
174 vectors form a solid cone. The algorithm also calculates the corresponding mass
175 flow rate value for each injection, as a function of its diameter assuming a Log-
176 Normal distribution. It is ensured that the sum of all mass flow rates in the file
177 equals the total mass flow rate defined initially. The total number of injections on
178 the file was 16,200.
179 The formulation properties of the pMDI spray droplets were assumed to be
180 composed by partial factions of HFA-134a (91.1 % w/w), ethanol (8.5 % w/w)
181 and salbutamol (0.4 % w/w) [23]. The properties for each component are listed in
182 Table 1.
183 The spray parameters used to configure the solver were obtained from various
184 references, though some caution is required.
185 3.2 Geometry and Grid
186 The domain geometry was taken as a ‘‘testbox’’ consisting of a simple parallele-
187 piped form with the dimensions of 0.2 9 0.2 9 0.3 m representing a fraction of a
188 room environment. The pMDI actuator and canister was included in the middle of
Table 1 Thermo-physical properties of the formulation
Properties HFA-134a Ethanol Salbutamol
Density (kg/m3) 1,311 790 1,230
Specific heat (J/kg K) 982 2,470 –
Latent heat (J/kg) 182,000 855,237 –
Boiling point (K) 247 351 –
Binary diffusivity (m2/s) 9.709E-6 1.370E-5 –
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189 it. The spray injection point, the actuator’s nozzle, is located in the origin point,
190 see Fig. 4. The geometry was drawn using an external design program and then
191 loaded into the ANSYS platform.
192 The numerical grid, by discretization of the domain, was generated, consisting
193 in tetrahedral and wedge elements, with sizes ranging from 0.1 to 20.0 mm. That
194 resulted in a computational grid of 3,060,339 elements and 1,022,403 nodes.
195 Several refinements, close to the wall zones of high proximity and curvature, were
196 included (as shown in Fig. 5). The grid quality reports showed a good quality
197 according to the Skewness parameter, with an average value of 0.21.
198 The boundary conditions were defined as: a ‘Velocity Inlet’ (see Fig. 4 ‘‘A’’),
199 forcing air to move uniformly inside the domain at 0.01 m/s and with a temper-
200 ature of 293 K; and an ‘Outflow’ (see Fig. 4 ‘‘B’’), enabling the freely motion of
201 the air, as well as particles. For the remaining four external walls, a ‘Symmetry’
202 boundary condition was assumed. The pMDI actuator and canister boundaries
203 were considered ‘Wall’, trapping all the particles that collide with them.
Fig. 4 A ‘‘testbox’’
representation where, the red
plane (A) is the boundary
condition ‘velocity inlet’ and
the green plane (B) is the
boundary ‘outflow’
Fig. 5 3D domain grid
representation, focusing the
pMDI walls refinements for
proximity and curvature
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204 3.3 CFD Configuration
205 To account for the transient effects of a real pMDI spray plume, an unsteady
206 simulation was made using a time step of 0.01 s for the flow field and 0.005 s for
207 the particle tracking. The solution of the differential equations for mass and
208 momentum was done in a sequential manner, using the SIMPLE algorithm [24–26].
209 The standard discretization scheme was used for the pressure and the second order
210 upwind scheme for the energy, turbulence, momentum and air species concentra-
211 tion equations.
212 For the turbulence calculation, the SST k–x model was used. This model is
213 adequate for low-Re simulations and it has been used in the literature for this type
214 of flow [10, 27–29].
215 Convergence was reached in the simulation by using a criterion value of 1.0E-5
216 for the continuity (pressure), velocity components, turbulence, species and a value
217 of 1.0E-10 for the energy.
218 Droplets were considered as being multi component, as described above, where
219 only the HFA is evaporating into the environment. This is initially simulated
220 without any HFA gas, as well as, the air entering by the ‘‘velocity Inlet’’ boundary.
221 As the HFA fraction is evaporating, it drastically reduces the diameter of the
222 droplet, and changes its trajectory. On the other hand, the HFA concentration in
223 the environment increases, making it harder for more particles to evaporate in
224 areas of high concentration. The gravitational acceleration was assumed 9.81 m/s2
225 along the y axis direction. For the configuration of the Discrete Phase Model
226 (DPM) droplet tracking model, the drag between both phases, Brownian motion
227 for small particles and turbulence exchange were accounted. Through a User
228 Defined Function (UDF), a customized drag law was included in the solver. This
229 law was based in the work of Clift and his collaborators plus a correction for
230 particles below 1 lm known as the Cunningham correction slip factor [28, 30].
231 The total number of particle streams injected during the simulation was
232 approximately 323,200.
233 4 Results
234 4.1 Contour Fields
235 Figures 6, 7 and 8 show the contours for air velocity magnitude, air temperature
236 and spray mass concentration, respectively, taken at a XY plane located at z = 0
237 and t = 0.1 s. The air velocity field (see Fig. 6) ranges from 0.0 to 3.27 m/s, being
238 the lowest value found in almost all domain, because the ambient air was assumed
239 stagnant. The maximum value is found at the nozzle exit, resulting from
240 momentum exchange imposed by the high velocity spray particle injection.
A CFD Study of a pMDI Plume Spray 9
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241 Observing the air temperature (see Fig. 7), it can be concluded that it ranges
242 from 289.89 to 293.15 K, where the higher variation can be found at the spray
243 plume formation zone. A sudden drop of 3.3 K occurs at the nozzle exit, due to the
244 injection of droplets with an initial temperature of 215.15 K [22]. This temperature
245 drop results from the energy exchange needed to evaporate the propellant.
246 Analyzing the HFA mass fraction present in the air (see Fig. 8), it can be
247 perceived that its value is between 0 and 2.9E-3. The higher concentration zone,
248 at the end of the injection period (t = 0.1 s), is located ahead of the nozzle, more
249 specifically at the exit of the pMDI actuator mouthpiece. It has the shape of a spray
250 plume. As expected, the droplets evaporate more in the periphery of the actuator
251 zone, where HFA diffusion into the air is more effective.
252 4.2 Particle Trajectory
253 As shown in Fig. 9, the particle velocity magnitude in the spray plume ranges from
254 approximately 100 m/s (as described in Sect. 3.1) to 0.01 m/s (the input air
255 velocity as described in Sect. 3.2). The particles located downstream the actuator
256 mouthpiece decelerate rapidly until they match the air velocity. Larger particles
Fig. 6 Air velocity
magnitude contours took at
the XY plane (z = 0 and
t = 0.1 s)
Fig. 7 Air temperature
contours took at the XY plane
(z = 0 and t = 0.1 s)
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257 travel further into the still air than smaller ones. The influence of the gravitational
258 acceleration is noticeable for higher particles when the slip velocity equals zero.
259 After other post-processing of the CFD results, took at different nozzle dis-
260 tances, results were obtained (see Figs. 10, 11).
261 In Fig. 10, the average velocity of the drug particles/droplets, took at the spray
262 plume centerline for different distances from the nozzle, is reported. The results
263 are then compared against data reported by Dunbar [18] for a formulation
Fig. 8 HFA mass fraction
contours took at the XY plane
(z = 0 and t = 0.1 s)
Fig. 9 Representation of the
particle streams at the end of
the injection (t = 0.11 s),
with particles colored by its
velocity magnitude. The
particle streams are draw as
spheres with proportional size
scaled 20 times more than the
real diameter
Fig. 10 Comparison of
Dunbar [18] data with our
CFD results, in terms of
particle averaged velocity
along the axial distance from
the nozzle of a pMDI using a
formulation only with
HFA-134a
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264 containing only HFA 134a. A good agreement between the CFD and the experi-
265 mental results was found.
266 Figure 11 reports the Mass Mean Aerodynamic Diameter (MMAD), which is a
267 common pharmaceutical measure to evaluate the size distribution of particles. This
268 was calculated by considering the mass in the cumulative form and plotted against
269 its corresponding diameter. Then, the diameter for which the mass fraction reached
270 50 % of the total was calculated. The results show that the value of MMAD
271 increases with the distance from the nozzle, which can be indicative that particles
272 of higher diameter travel further than the smaller ones.
273 5 Conclusions and Future Work
274 The study herein reported the characterization of a pMDI spray plume, of salbu-
275 tamol and HFA-134a as propellant. The spray plume showed to be a transient jet,
276 with effects that are dependent on the canister pressure. There is no constant
277 delivery of the spray plume, but almost all the dose is aerosolized in the first 4/10
278 of the spray duration.
279 Microscopy showed that particles do not present a regular shape when in solid/
280 dry state, although if they are involved in propellant they are almost spherical. The
281 existence of a multi-component droplet confirmed the need for that approach in the
282 simulation.
283 The aerodynamic size distribution of the pMDI sprays are usually accurately
284 fitted by Log-Normal distribution. This was confirmed showing a good coefficient
285 of determination for the experimental data obtained by laser diffraction analysis.
286 The spray characteristics were introduced in the CFD model and the spray
287 droplets trajectory calculated in still air. Results showed that air temperature can
Fig. 11 Representation of
the mass mean aerodynamic
diameter along the axial
distance from the nozzle
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288 drop over 3.3 K and increase its velocity 3.27 m/s, in the proximities of the
289 actuator’s nozzle.
290 A good agreement between the CFD and the experimental data from Dunbar
291 [18] was found, regarding the average velocity along the axial distance. Also, it
292 was found that the MMAD value increases with the axial distance.
293 Spray characteristics used contributed to a correct configuration of the spray in
294 the CFD software.
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